References to accompany the June 2016 issue of Kai Tiaki Nursing New Zealand

1. Monsenifar, Z.  (2016). Chronic obstructive pulmonary disease. Medscape reference. Accessed April 2016. 
2. Lopez-Campos J., Tan, W. & Soriano, J. (2016). Global burden of COPD. Respirology. 21: 14-23.
3. GOLD. (2016). Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease. Available from: http://www.goldcopd.org/.
4. Glasgow, N. (2011). COPD-X Guidelines. Australian and New Zealand http://copdx.org.au/copd-x-plan/foreword/
5. Milne, R. & Beasley, R. (2015). Hospital admissions for chronic obstructive pulmonary disease in New Zealand. The New Zealand Medical Journal. 128(1408): 23-36.
6. Ministry of Health (NZ). (2009). Report on New Zealand cost-of-health studies on long-term conditions. Wellington: Ministry of Health.
7. Postma, D., Bush, A. & van den Berge, M. (2015). Risk factors and early origins of chronic obstructive pulmonary disease. The Lancet. 385: 899-909.
8. Decramer, M., Janssens, W. & Miravittles, M. (2012). Chronic obstructive pulmonary disease. The Lancet.379(9823): 1341-1351.
9. Marsland, B. & Gollwitzer, E. (2014). Host-microorganism interactions in lung diseases. Nature Reviews Immunology. 14: 827-836.
10. Dickson, R., Martinez, F. & Huffnagle, G. (2014). The role of the microbiome in exacerbations of chronic lung diseases. The Lancet. 384: 691-702.
11. CDC – Centres for Disease Control. (2010). How tobacco smoke causes disease: The biology and behavioural basis for smoking-attributable disease: A report of the Surgeon General. Atlanta GA: Centres for Disease Control and Prevention (US).
12. Xu, J. et al. (2015) Effects of environmental tobacco smoking during early life stages. Chapter 21 in Harding, R. & Pinkerton, K. (eds.). The Lung: Development, aging and the environment. (2^nd ed.). London: Elsevier.
13. Shaykhiev, R. & Crystal, R. (2014). Early events in the pathogenesis of chronic obstructive pulmonary disease. Annals of the American Thoracic Society. 11(suppl. 5): S525-S529.
14. Sohal, S. et al. (2013). Recent advances in understanding inflammation and remodelling in the airways in chronic obstructive pulmonary disease. Expert Reviews in Respiratory Medicine. 7(3): 275-288.
15. Kim, V. & Crimer, G. (2013). Chronic bronchitis and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 187(3): 228-237.
16. Kent, B., Mitchell, P. & McNicholas, W. (2011). Hypoxemia in patients with COPD: cause, effects and disease progression. International Journal of Chronic Obstructive Pulmonary Disease.  6: 199-208.
17. Brown, J. & Martinez, C. (2016). Chronic obstructive pulmonary disease comorbidities. Current Opinion in Pulmonary Medicine. 22: 113-118.
18. Orr, R., Smith, L. & Cuttica, M. (2012). Pulmonary hypertension in advanced chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine. 18(2): 138-143. 
19. Durham, A. & Adcock, I. (2015). The relationship between COPD and lung cancer. Lung Cancer. 90(2): 121-127.
20. Strong, M. et al. (2014). Accuracy of diagnosis and classification of COPD in a primary and specialist nurse-led respiratory care in Rotherham, UK: a cross-sectional study. Primary Care Respiratory Journal. 23: 67-73.
21. Berndt, A., Leme, A. & Shapiro, S. (2012). Emerging genetics of COPD. EMBO Molecular Medicine. 4:1144-1155.